We further demonstrated that DHA decreased the expression of P-gp via inhibiting p53 (R248Q)-ERK1/2-NF-κB signaling, which leads to the reversal of ADM resistance in p53 (R248Q)-expressing HCC cells. The gene discussed is TP53; the disease is hepatocellular carcinoma.